Flexmore 8mg Injection

Introduction

Flexmore is a prescription medication that contains the active ingredient Lornoxicam. It is available under the brand name Flexmore. This medication is primarily used as a nonsteroidal anti-inflammatory drug (NSAID) to relieve pain and reduce inflammation.

Uses

Flexmore is commonly prescribed to manage pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other musculoskeletal disorders. It helps alleviate symptoms such as joint pain, swelling, and stiffness.

Dosage and Administration

The dosage of Flexmore will be determined by your healthcare provider based on your specific condition and other factors. It is typically administered as an injection into a muscle or a vein.

Follow the dosage instructions provided by your healthcare professional. Do not exceed the recommended dose or use the medication for longer than prescribed.

Mechanism of Action

The active ingredient in Flexmore, Lornoxicam, belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain substances in the body that cause pain, inflammation, and fever. By reducing the levels of these substances, Lornoxicam helps relieve pain and reduce inflammation.

Side Effects

Common side effects may include nausea, vomiting, stomach upset, headache, dizziness, and skin rash. These side effects are usually mild and transient.

In rare cases, some individuals may experience more serious side effects such as severe allergic reactions, stomach bleeding, liver problems, kidney problems, or cardiovascular events. If you experience any severe or persistent side effects, seek medical attention immediately.

Drug Interactions

Flexmore may interact with other medications, including but not limited to:

• Other NSAIDs
• Anticoagulants (blood thinners)
• Antiplatelet drugs
• Corticosteroids
• Selective serotonin reuptake inhibitors (SSRIs)
• Diuretics

inform your healthcare provider about all the medications you are currently taking, including prescription medications, over-the-counter drugs, and herbal supplements. They can provide guidance on potential interactions and adjust your treatment plan accordingly.

Precautions

Before using Flexmore, inform your healthcare provider about any existing medical conditions you have, especially if you have a history of gastrointestinal ulcers, bleeding disorders, liver or kidney problems, or cardiovascular disease.

This medication should be used with caution in individuals who are allergic to NSAIDs or have a history of asthma or other respiratory conditions. Follow your healthcare provider’s instructions and report any new or worsening symptoms during treatment.

Flexmore should not be used during pregnancy or while breastfeeding without consulting your healthcare provider.

Storage

Flexmore should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Flexmore exactly as prescribed by your healthcare provider. Do not change the dosage or stop the medication without consulting them.
• If you experience any unusual or severe side effects, contact your healthcare provider immediately.
• Inform your healthcare provider about all the medications, supplements, and herbal products you are taking before starting Flexmore.
• Avoid consuming alcohol while taking this medication, as it may increase the risk of stomach bleeding.
• Follow any additional instructions provided by your healthcare provider regarding diet, exercise, and lifestyle modifications to manage your condition effectively.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Lornoxicam (International database) (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• Ahmed MO, Al-Badr AA. Lornoxicam. Profiles Drug Subst Excip Relat Methodol. 2011;36:205-39. doi: 10.1016/B978-0-12-387667-6.00006-3. Epub 2011 Jun 23. [Accessed 6 Jun. 2024] Available at:
• Hall PE, Derry S, Moore RA, McQuay HJ. Single dose oral lornoxicam for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD007441. doi: 10.1002/14651858.CD007441.pub2. [Accessed 24 Jun. 2024] Available at:
• Dadej A, Woźniak-Braszak A, Bilski P, Piotrowska-Kempisty H, Józkowiak M, Pawełczyk A, Dadej D, Łażewska D, Jelińska A. Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods. Eur J Pharm Sci. 2022 Apr 1;171:106133. doi: 10.1016/j.ejps.2022.106133. Epub 2022 Jan 21. [Accessed 21 Jun. 2024] Available at: